Related Experiment Videos
Benign prostatic hyperplasia: what about a campaign for prevention?
F Di Silverio1, V Gentile, A L Pastore
1Department of Urology, University la Sapienza, Rome, Italy.
Urologia Internationalis
|April 16, 2004
Summary
Benign prostatic hyperplasia (BPH) prevention is being explored, but more research is needed to establish effective primary prevention strategies. Current data primarily supports secondary prevention for BPH progression.
Area of Science:
- Urology
- Preventive Medicine
- Men's Health
Background:
- Benign prostatic hyperplasia (BPH) significantly impacts the male population and quality of life.
- Understanding of BPH etiopathogenesis is advancing.
- The rationale for BPH prevention is under consideration.
Purpose of the Study:
- To explore the feasibility and rationale for benign prostatic hyperplasia (BPH) prevention programs.
- To review current knowledge and identify gaps in BPH prevention research.
Main Methods:
- Searched Medline and Current Content databases for studies on BPH prevention within the last 10 years.
- Reviewed literature on BPH etiopathogenesis, risk factors, and potential preventive agents.
Main Results:
- Established criteria for promoting BPH prevention exist.
- Data for secondary prevention of BPH progression is more available than for primary prevention.
- Experimental evidence for natural/nutritional agents exists, but clinical trial data is lacking.
- Synthetic agents' efficacy for primary BPH prevention is not yet reported.
Conclusions:
- A BPH prevention program is proposed as a foundation for future research and discussion.
- Further clinical trials are necessary to validate primary prevention strategies for BPH.